SCHEMBL22473648

SCHEMBL22473648

CNc1ncc2cc(-c3cc(NC(=O)C(C)C)c(F)cc3C)c(C)nc2n1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRAF P15056 11/20 0.70
▸ RAF1 P04049 11/20 0.70
▸ KDR P35968 8/20 0.70
▸ KRAS P01116 7/20 0.70
▸ ABL1 P00519 4/20 0.70
▸ ARAF P10398 3/20 0.70
▸ MAPK14 Q16539 2/20 0.70
▸ MAPK13 O15264 1/20 0.70
▸ FYN P06241 1/20 0.70
▸ SRC P12931 1/20 0.70
▸ EPHA2 P29317 1/20 0.70
▸ CSK P41240 1/20 0.70
▸ MAPK8 P45983 1/20 0.70
▸ MAPK9 P45984 1/20 0.70
▸ IRAK1 P51617 1/20 0.70
▸ MAPK12 P53778 1/20 0.70
▸ MAPK10 P53779 1/20 0.70
▸ EPHB4 P54760 1/20 0.70
▸ MAP2K5 Q13163 1/20 0.70
▸ MAP3K1 Q13233 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15269365 0.89 BRAF (0.72) BRAFRAF1KDRKRASABL1
SCHEMBL22360887 0.89 BRAF (0.71) BRAFRAF1KDRKRASABL1
SCHEMBL16683482 0.84 RAF1 (0.77) BRAFRAF1KDRKRASABL1
Ly-3009120 SCHEMBL29479162 0.83 RAF1 (1.00) BRAFRAF1KDRKRASABL1
Ly-3009120 SCHEMBL29356086 0.83 RAF1 (1.00) BRAFRAF1KDRKRASABL1
Ly-3009120 SCHEMBL15241297 0.83 RAF1 (1.00) BRAFRAF1KDRKRASABL1
SCHEMBL16682363 0.82 RAF1 (0.77) BRAFRAF1KDRKRASABL1
SCHEMBL16667718 0.82 RAF1 (0.77) BRAFRAF1KDRKRASABL1
SCHEMBL16682374 0.82 BRAF (0.64) BRAFRAF1KDRKRASABL1
SCHEMBL16667639 0.81 BRAF (0.65) BRAFRAF1KDRKRASABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10787443-B2 RAF-degrading conjugate compounds ZAMBONI CHEM SOLUTIONS INC. (CA) 2020-09-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10787443-B2 RAF-degrading conjugate compounds BRAF, RAF1, ARAF BRAF 1/4885RAF1 2/4885KDR 716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback